Eric Bash, PA
Physician Assistant · Azle, TXNPI 1548896749
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,780 of the $2,344 with a category attached, or 76.0%. It is spread thinly across 23 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $942 and has fallen 89.7% since, to $98 in 2025.
Across 91 payments — averaging $25.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$514
- AbbVie$410
- Novo Nordisk$354
- Biohaven Pharmaceuticals, Inc.$198
- Nestle Healthcare Nutrition Inc.$136
- Boehringer Ingelheim$132
- plus $600 from 17 others
What the payments were for
- Food & beverage$1,78076%
- Education$502%
- Other$51422%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 1 | $514 |
| AbbVie | 16 | $410 |
| Novo Nordisk | 28 | $354 |
| Biohaven Pharmaceuticals, Inc. | 10 | $198 |
| Nestle Healthcare Nutrition Inc. | 2 | $136 |
| Boehringer Ingelheim | 7 | $132 |
| Lundbeck LLC | 2 | $116 |
| Currax Pharmaceuticals LLC | 6 | $103 |
| Lilly USA, LLC | 4 | $66 |
| Integra Lifesciences Corporation | 1 | $45 |
| Avita Medical Americas, LLC | 1 | $39 |
| Aroa Biosurgery Incorporated | 1 | $27 |
| Davol Inc. | 1 | $26 |
| Amgen | 1 | $26 |
| Amarin Pharma, Inc. | 2 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Vivus LLC | 1 | $19 |
| Pfizer | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Bayer | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$124
- ZENPEP$119
- Wegovy$107
- UBRELVY$104
How this compares
$2,344 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 12 | $403 |
| Fluticasone Propionate | 20 | $235 |
| Levothyroxine Sodium | 13 | $191 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Azle
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.